New Study Reports: Nusinersen raises SMN Protein Levels

Exicure to Present Data at the CureSMA Annual Conference in Dallas SKOKIE, Ill.–(BUSINESS WIRE)–Exicure, Inc. (OTCQB:XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing three-dimensional, spherical nucleic acid (SNA™) constructs, announced today that Exicure and its collaborators at The Ohio State University Wexner Medical Center will show preclinical data… Att fortsätt läsa